Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006
Open Access
- 9 September 2012
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 754
- https://doi.org/10.1186/1471-2458-12-754
Abstract
Despite advances made in treating coronary heart disease (CHD), mortality due to CHD in Syria has been increasing for the past two decades. This study aims to assess CHD mortality trends in Syria between 1996 and 2006 and to investigate the main factors associated with them.Keywords
This publication has 56 references indexed in Scilit:
- Overweight and Obesity in Eastern Mediterranean Region: Prevalence and Possible CausesJournal of Obesity, 2011
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Rosuvastatin in Older Patients with Systolic Heart FailureNew England Journal of Medicine, 2007
- Cardiovascular Health among Adults in Syria: A Model from Developing CountriesAnnals of Epidemiology, 2007
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- Reducing The Growing Burden Of Cardiovascular Disease In The Developing WorldHealth Affairs, 2007
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsPublished by Elsevier ,2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists CollaborationPublished by Elsevier ,1994